Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

BioTime, Inc. (BTX)

Add BTX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 12/18/2014 8:55:22 PM - Followers: 62 - Board type: Free - Posts Today: 0


BioTime, Inc.  (BTX)





Company Information:

BioTime, Inc.
1301 Harbor Bay Parkway
Alameda, CA 94502

Phone: 510-521-3390
      Fax: 510-521-3389






BioTime, Inc. (NYSE AMEX: BTX) is a biotechnology company engaged in two areas of biomedical research and product development:

  • Stem cell technology and products for use in regenerative medicine.  These products and technologies are being developed and marketed by our wholly owned subsidiary Embryome Sciences, Inc.
  • Blood plasma volume expanders and related technology for use in surgery, emergency trauma treatment and other applications.  Our lead product is Hextend® which is being marketed by Hospira, Inc. and CJ CheilJedang Corp. under exclusive licenses from us


The Potential of Regenerative Medicine

Regenerative medicine refers to therapies based on human embryonic stem ("hES") cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. The great scientific and public interest in regenerative medicine lies in the potential of hES cells to transform into any cell type of the human body. hES cells therefore show considerable potential as a source of new therapies for a host of currently-incurable diseases such as: diabetes, stroke, Alzheimer's and Parkinson's disease, heart failure, arthritis, muscular dystrophy, spinal cord injury, macular degeneration, hearing loss, kidney and liver failure, as well as many other disorders that may be treated by replacing diseased or damaged organ tissues. In response to the unusual potential of the field, the State of California has allocated $3 billion over the next 10 years to fund basic research, and President Obama has lifted previous restrictions for federal funding of stem cell research.

Led by Dr. Michael West, considered by many to be a founding father of the stem cell industry, BioTime has assembled an array of products and associated intellectual property that give it the potential to be a leader in this exciting new field of medicine.

We are implementing a near-term revenues strategy in the regenerative medicine field by seeking to develop and market advanced hES products and technology that can be used by researchers at universities and biopharmaceutical companies. These research-only products generally can be marketed without regulatory (FDA) approval, and are therefore relatively near-term business opportunities when compared to human therapeutic products. We may also initiate development programs for human therapeutic applications if sufficient capital becomes available to us or through joint efforts with industry partners.

BioTime is leveraging its product development strategy on two key technology platforms:

  • • An advanced iPS technology allowing the transformation of human cells of the body back to a primordial stem cell state equivalent to embryonic stem cells. Using this technology with patient specific stem cells, rather than stem cells derived from embryos donated by unrelated people, may reduce the incidence of rejection of tissue grafts.
  • ACTCellerate™ technology that permits the generation of scalable and highly purified cells of the human body.

See this link for more information:









Dr. Michael West, CEO

Dr. West is the Chief Executive Officer of BioTime, Inc. (NYSE AMEX: BTIM) and Embryome Sciences, Inc. of Alameda, California. The Companies are focused on developing an array of research and therapeutic products using human embryonic stem cell technology. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He has focused his academic and business career on the application of developmental biology to the age-related degenerative disease. He was the Founder of Geron Corporation of Menlo Park, California (Nasdaq: GERN) and from 1990 to 1998 he was a Director, and Vice President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells. From 1995 to 1998 he organized and managed the research collaboration between Geron and its academic collaborators James Thomson and John Gearhart that led to the first isolation of human embryonic stem and human embryonic germ cells. From 1998 to 2007 he was President and Chief Scientific Officer at Advanced Cell Technology, Inc. (OTCBB: ACTC) where he managed programs in animal cloning, human somatic cell nuclear transfer, retinal differentiation, and ACTCellerate, a technology for the multiplex derivation and characterization of clonal human embryonic progenitor cell lines. 

Dr. West's complete CV and background on his research interests are available online at:





Recent News:








Transfer Agent:

American Stock Transfer & Trust Company
59 Maiden Lane
New York 10038


Investor Relations:

Judith Segall

VP of Administration, Corporate Secretary

Phone:  510.521.3390 ext 301






All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.   Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BTX News: Initial Statement of Beneficial Ownership (3) 12/16/2014 04:17:58 PM
BTX News: BioTime Subsidiary ES Cell International and GE Healthcare Cross-License patents in the Field of Cell Assays for Drug Testing 12/15/2014 12:00:00 PM
BTX News: BioTime, Inc. Subsidiary OncoCyte Corp. Completes Initial Enrollment of Clinical Study of Urine-Based Bladder Cancer Diagnostic 12/15/2014 11:00:00 AM
BTX News: BioTime Appoints Angus C. Russell to Board of Directors 12/15/2014 08:38:00 AM
BTX News: Current Report Filing (8-k) 12/15/2014 08:25:13 AM
#434   Are you talking about the BTX website? tradetrak 12/18/14 08:55:22 PM
#433   Watch it. It's in the site Adi2 12/18/14 11:28:59 AM
#432   Very nice move today. Response to the 12/15 tradetrak 12/17/14 10:23:22 PM
#431   Sleeping giant poonch1ne 12/16/14 09:06:25 AM
#430   Anybody hear anything from the investors conference today? tradetrak 12/15/14 08:02:56 PM
#429   Oh, you will get way more, over time. Adi2 12/10/14 11:44:33 AM
#428   I don't know about being ready for the tradetrak 12/09/14 10:49:05 PM
#427   Are you ready for Pan Dx results? This little Adi2 12/09/14 01:18:38 PM
#426   Hmmm. Okay. I guess I'm just always amazed tradetrak 11/23/14 10:36:41 PM
#425   Just shorting on think we will see shorts Kyle3 11/23/14 03:20:49 PM
#424   Anybody have any thoughts on why we're down tradetrak 11/22/14 02:47:45 PM
#423   Fantastic progress. The market still looks at everything Adi2 11/14/14 07:16:20 AM
#422 Stock Guy777 11/10/14 04:17:25 PM
#421   ;-) $$$BTX$$$ Stock Guy777 11/10/14 01:36:19 PM
#420   WAKE-UP YALL, "BTX" ABOUT TO GO INTO ORBIT! envirogym 11/10/14 01:22:38 PM
#419   LOOKS LIKE ALL THE PAST RESEARCH IS PAYING OFF. envirogym 11/04/14 04:07:21 PM
#418   BioTime Receives Authorization to Begin Pivotal Human Clinical alien42 11/04/14 12:50:38 PM
#417   One FDA step closer! $BTX$ Stock Guy777 11/03/14 01:20:06 PM
#416   BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization Stock Guy777 11/03/14 01:19:16 PM
#415   SOOOOOOOOOOOO, what's the news? envirogym 11/03/14 01:07:25 PM
#414   Awesome news today!!! :-) Stock Guy777 11/03/14 12:59:31 PM
#413   BTX TO BE AT $5 PLUS SOON, GROSSLY UNDERVALUED, envirogym 10/28/14 07:45:40 PM
#412   Hmmm. Up nicely on more than 2x avg. tradetrak 10/28/14 04:07:58 PM
#411   DEVELOPMENT IN THE WORKS, NEW PRODUCTS IN LINE envirogym 10/09/14 04:21:41 PM
#410   Half million volume in first couple minutes poonch1ne 10/03/14 09:35:10 AM
#408   BIOTIME BRANCHING OUT INTO BROADER FIELDS. envirogym 10/01/14 06:35:48 PM
#407   This play is like someone hiding a 5000 poonch1ne 09/24/14 01:27:09 AM
#406   So much going on its like owning 5 Adi2 09/23/14 11:18:39 PM
#405   Ditto that, Enviro! Can't believe how quiet this tradetrak 09/16/14 10:17:06 PM
#404   WELL NOW THAT THE TRIALS ARE APPROVED. envirogym 09/16/14 09:34:12 PM
#403   Exactly. Been holding for two years now! ;-) Stock Guy777 09/11/14 07:54:10 AM
#402   GOOD MORNING BTX BioTime, Inc. has added a Stock Guy777 09/11/14 07:52:38 AM
#401   WARRANTS ARE GOING FOR $5, THIS STOCK IS envirogym 09/09/14 04:31:45 PM
#400   VOLUME KICKING IN. BIOTIME IS ON ITS WAY. envirogym 09/08/14 05:18:33 PM
#399   Looks like consolidation setting in. envirogym 09/05/14 08:48:50 PM
#398   MENLO PARK, Calif., Sept. 4, 2014 /PRNewswire/ -- K1 09/05/14 04:20:19 PM
#397   Agreed. Looking forward to hearing what they are tradetrak 08/22/14 11:25:53 PM
#396   Asty will behave like a Classic spinoff stock Adi2 08/22/14 12:00:39 AM
#395   I got some ASTY shares from the GERN tradetrak 08/21/14 09:58:27 PM
#394   Quietly, doing all the right things. New product Adi2 08/21/14 01:38:26 PM
#393   PREMVIA, MAJOR BREAKTHROUGH! envirogym 08/13/14 05:33:00 PM
#392   Somebody likes the 8-k, this will sneak up poonch1ne 08/12/14 01:13:04 PM
#391   Asterias is to be listed "This summer". At Adi2 07/04/14 09:25:29 AM
#390   "BTX" IS READY TO BREAK OUT! envirogym 06/19/14 12:46:02 PM
#389   STEM CELL TECHNOLOGY IS THE FUTURE! envirogym 06/17/14 12:01:27 PM
#387   Also pat cox replacement got spooked on a Dynarod 06/15/14 05:25:53 AM
#386   CHECK OUT THE NEW TALENT COMING INTO THE COMPANY! envirogym 06/12/14 07:04:47 PM
#385   Tom, The way I see and use Adi2 06/12/14 05:04:28 PM
#384   well, yes it seemed to be a promo 123tom 06/11/14 05:45:20 PM